| COVID-19, impact on myeloma patients #MMPMID32577846Dufour I; Raedemaeker J; Andreozzi F; Verstraete G; Bailly S; Delforge M; Storms P; Jacquy C; Van de Velde A; Mineur P; Lejeune M; Bauwens D; Van Obbergh F; Kentos A; Nguyen J; Fostier K; De Weweire A; Meuleman N; Vekemans MCAnn Hematol 2020[Aug]; 99 (8): 1947-1949 PMID32577846show ga
ä|*Betacoronavirus[MESH]|*Surveys and Questionnaires[MESH]|Aged[MESH]|Aged, 80 and over[MESH]|Belgium/epidemiology[MESH]|COVID-19[MESH]|Coronavirus Infections/diagnosis/*epidemiology[MESH]|Female[MESH]|Humans[MESH]|Male[MESH]|Middle Aged[MESH]|Multiple Myeloma/diagnosis/*epidemiology[MESH]|Pandemics[MESH]|Pneumonia, Viral/diagnosis/*epidemiology[MESH]
DeepDyve Pubget Overpricing |
|